Home | About Dr. Robbins | Archived Articles | Headache Books | Topic Index |
Title: |
Frovatriptan: Patient Preference and Efficacy in |
|
Background and Objectives: In studies of moderate to severe migraine, frovatriptan has demonstrated consistent efficacy with a long duration of action. Preliminary data from open-label studies indicated that frovatriptan used early provided more rapid relief with no effect on migraine recurrence. This study sought to compare early use of frovatriptan with placebo and also with frovatriptan used later in the migraine attack.
Home | About Dr. Robbins | Archived Articles | Headache Books | Topic Index Copyright © 2002- Lawrence Robbins, MD |